NASDAQ:GLUE | Profit Breakdown | Monte Rosa Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$8.97M-$49.13M-$43.19M-$43.4M
2026-03-31$4.21M-$50.03M-$44.45M-$44.5M
2025-12-31$2.78M-$49.72M-$46.08M-$46.14M
2025-09-30$12.77M-$32.98M-$30.26M-$27.08M
2025-06-30$23.19M-$15.55M-$11.1M-$12.3M
2025-03-31$84.93M$44.04M$47.71M$46.89M
2024-12-31$60.65M$13M$15.6M$13.44M
2024-09-30$9.22M-$26.53M-$23.79M-$23.86M
2024-06-30$4.7M-$32.64M-$30.06M-$30.31M
2024-03-31$1.06M-$34.95M-$31.89M-$31.97M
2023-12-31$0.00-$34.86M-$33.27M-$33.25M
2023-09-30$0.00-$36.97M-$34.71M-$34.88M
2023-06-30$0.00-$37.22M-$34.99M-$35.18M
2023-03-31$0.00-$34.26M-$32.04M-$32.04M
2022-12-31-$32.49M-$30.78M-$30.78M
2022-09-30-$28.36M-$27.32M-$27.32M
2022-06-30-$27.23M-$26.47M-$26.47M
2022-03-31-$24.3M-$23.93M
2021-12-31-$23.39M-$23.44M
2021-09-30-$19.87M-$19.84M
2021-06-30-$18.12M-$18.41M
2021-03-31-$11.5M-$12.28M
2020-12-31-$11.94M-$19.66M
2020-09-30-$6.39M-$6.56M
2020-06-30-$5.4M-$5.36M
2020-03-31-$4.3M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$123.67M-$54.21M-$39.72M-$38.63M
2024-12-31$75.62M-$81.11M-$70.13M-$72.7M
2023-12-31$0.00-$143.31M-$135.01M-$135.35M
2022-12-31-$112.38M-$108.5M-$108.5M
2021-12-31-$72.88M-$73.96M
2020-12-31-$28.01M-$35.88M